Opioid Withdrawal Treatment Market Overview
In 2018, the global opioid withdrawal therapy market was worth USD 1.8 billion, and it is expected to increase at a CAGR of 10.1 percent over the next five years. Opioids include heroin, opium, morphine, codeine, and methadone, which are used to treat severe, chronic, or postsurgical pain. Opioid abuse can lead to addiction, and opioid withdrawal syndrome is a life-threatening illness caused by opioid addiction. These medicines can potentially cause serious health problems and, in rare cases, overdose and death. As a result, this opioid addiction necessitates treatment, which is referred to as opioid withdrawal treatment market share.
Opioid Withdrawal Treatment Market Segmentation
The global opioid withdrawal treatment market has been segmented into drug type and distribution channel.
- By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, analgesics, natural sleep supplements, and others.
- On the basis of distribution channel, the market has been segmented into hospital pharmacy, retail pharmacies, and online stores.
Opioid Withdrawal Treatment Market Regional Analysis
On a regional basis, the Americas is anticipated to dominate the global opioid withdrawal treatment market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and rising adoption of opioids for the management of pain.
According to the Substance Abuse and Mental Health Services Administration (SAMHSA) in the National Survey on Drug Use and Health (NSDUH), about 30.5 million Americans aged 12 or older were using illicit drugs in 2018. Additionally, rising demand for advanced treatment and growing healthcare expenditure is driving the growth of the market. For instance, according to the American College of Cardiology Foundation, coronary heart disease (CHD) is the leading cause of deaths attributable to CV in the US. CHD contributes to over 43.8% of death cases in the US. Additionally, in 2015, the total healthcare expenditure for CVD and stroke in the US was an estimated USD 329.7 billion. CVD and stroke accounted for 14% of total health expenditures in 2015.
Europe accounts for the second-largest market and holds a healthy share in the global opioid withdrawal treatment market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing pharmaceutical industry due to the presence of major market players.
Opioid Withdrawal Treatment Market Players
Some of the prominent players in the global opioid withdrawal treatment market are Merck Co., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis, Sanofi, Johnson Johnson Services, F. Hoffmann-La Roche Ltd, and Bayer AG among others
among others are some key companies in the global Opioid Withdrawal Treatment that are listed by MRFR for market research.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
